(redirected from 001)
Also found in: Dictionary, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • all
  • noun
  • adj

Synonyms for 1

the smallest whole number or a numeral representing this number

used of a single unit or thing


Related Words

References in periodicals archive ?
The automaker will produce between 99 and 150 units of the AM-RB 001 at its Gaydon production facility.
The company stated that it will use a high-revving, naturally-aspirated V12 engine mounted in the middle of the AM-RB 001 to achieve that goal.
A press conference took place in Cairo recently and was attended by Frederick Sischller, Rotana Studios chairman, Ayman Halawani, the general director of Rotana Film, Nabil Farouq, the author of the Agent 001 novels, and scriptwriter Mohammed Hefzi.
A star to play Agent 001 has not been named, but Farouq hinted that he would like to see a new face.
When our CCSS Supply system gets a Priority 02/RDD 001 requisition, CCSS shows that the requisitioned item is not needed until Jan 1, 2005.
Units could be hurting their supply availability when they think that RDD 001 is a high priority designator.
Though temperature stability tests have not been done, Seltzman suspects that, like aspartame, 001 would not hold up in cooking, even though "it should be more stable than aspartame in hot drinks, like coffee.
This payment is triggered by Pfizer's decision to advance EXC 001 into a Phase 2 study.
35m in contingent payments upon achievement of various milestones associated with the clinical and commercial progress of EXC 001, also referred to as PF-06473871.
25m contingent payment from Pfizer Inc (NYSE:PFE) as the latter advances EXC 001 into a Phase 2 study.
M2 EQUITYBITES-4 August 2010-Excaliard Pharmaceuticals Inc reports improved data from Phase 2 clinical trial of EXC 001 for skin scarring(C)2010 M2 COMMUNICATIONS http://www.
Biotechnology company Excaliard Pharmaceuticals Inc said on Tuesday that the company has received positive results from its Phase 2 clinical trial of EXC 001, a new chemical entity for reducing fibrosis, in the randomised, double-blind multicentre study conducted in the US.